ArticleBriefings in bioinformatics2026
WDGTA: a wavelet-denoised graph attention framework for spatial transcriptomics deconvolution.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spatial transcriptomics (ST) facilitates the spatial resolution of gene expression profiling; however, many widely used spot-based sequencing platforms capture transcripts from multiple neighboring cells at each location, producing mixed profiles that require accurate cell-type deconvolution. The wavelet-denoised graph attention framework for spatial transcriptomics deconvolution (WDGTA), a graph attention-based framework for ST cell-type deconvolution, was developed and validated on five datasets from two species and four organs. Through the integration of real with pseudo-ST spots, WDGTA introduces a wavelet-based multiscale denoising and reconstruction module, constructs a weighted topological graph using random projection forests, and applies multi-head graph attention to infer cell-type proportions in spatial spots. WDGTA achieved optimal performance in comparison with seven established deconvolution methods. Ablation and discrete wavelet transform (DWT)-specific analyses confirmed the contributions of wavelet denoising, weighted graph construction, and semi-supervised learning. Furthermore, DWT performance remained stable after feature-order perturbation. In mouse brain, cerebellum and ultraviolet radiation (UVR) skin data, WDGTA recovered biologically consistent spatial cell-type patterns and demonstrated robust cross-platform applicability and improved resolution of low-abundance melanocyte signals. Furthermore, it accurately captured melanocyte-associated spatial changes under conditions of UVR exposure and drug intervention. WDGTA provides a unified framework for ST deconvolution across the evaluated tissue contexts. In UVR-exposed skin, it resolved localized melanocyte-associated patterns that were concordant with marker-gene evidence and detected changes associated with UVR exposure and drug treatment. These findings support its use for characterizing spatial cell-type organization and low-abundance cell populations in heterogeneous tissues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.